Enduring Material

Identification and Management of Perinatal Cannabis Use
View Activity Info
Enter Basic User Info
Create Account
Take Pretest
View Content
Take Post Test
Done
View Activity Info
Continue to Enduring Material
 
 
Colorado Medical Society

7351 Lowry Blvd, Suite 110
Denver, CO 80230-6902
General Information
Friday, May 1, 2026 - Tuesday, May 1, 2029
120 minutes
Rocky Mountain Prevention Research Center
Virtual Conference Room
RMPRC Enduring Materials
Colorado Medical Society
The training is an Enduring Material consisting of a structured self-paced curriculum. It utilizes a mix of literature review, evidence-based clinical guidelines, visual flow charts (e.g., the 5As Patient Flow Chart), and example scripts for patient-centered communication.
Objectives
  • Understand the potential harms related to perinatal cannabis use.
  • Identify current guidelines for prenatal and postnatal cannabis use.
  • Locate and utilize screening assessment tools for perinatal cannabis use.
  • Develop knowledge on available evidence-based treatments for perinatal cannabis use.
  • Develop skills to increase self-efficacy and intent to manage perinatal cannabis use.
  • Locate local and national resources for perinatal cannabis use.
Presentations and Speakers
Identification and Management of Perinatal Cannabis Use
  • Jennifer Leiferman, PhD
  • Sarah Gelinas, MPH
Available Credits/Points
  • The Colorado Medical Society designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The Colorado Medical Society designates this enduring material for a maximum of 2 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
This training aims to provide educational materials and best practice guidelines to support healthcare providers to identify and manage (i.e., treat or refer to care) perinatal cannabis use among pregnant and postpartum women. This training provides an overview of the risks of perinatal cannabis use on numerous maternal and child outcomes. It is based on the latest research and the current recommendations from leading governing bodies on cannabis use during pregnancy and the postpartum period. It will also enhance patient-provider communication using the 5As framework (i.e., Ask, Advise, Agree, Assist and Arrange) to guide providers to assess for perinatal cannabis use, advise the patient on the health risks and available treatment options, agree on a treatment plan, assist the patient in any problem solving related to obtaining treatment, and arrange for supports for the patient. Providers will learn how to communicate the current national guidelines, safety considerations, and employ brief counseling strategies related to perinatal cannabis use.
Disclosure Statements
Speakers:
Sarah Gelinas, MPH and Jenn Leiferman, PhD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Planners and other Administrative Support:
Sarah Gelinas, MPH has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and Rocky Mountain Prevention Research Center. The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
Test Information
80 %
100 %
5/1/2026
Continue to Enduring Material